PANACEABIO — Panacea Biotec Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹8.06bn
- IN₹6.38bn
- IN₹5.59bn
- 55
- 40
- 30
- 33
Annual cashflow statement for Panacea Biotec, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1,712 | -1,442 | 14,488 | 128 | 14.8 |
| Depreciation | |||||
| Non-Cash Items | 2,030 | 1,839 | -14,987 | -1,350 | -460 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1,062 | 209 | -1,022 | -3,394 | 77.1 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -302 | 1,067 | -1,084 | -4,225 | -1 |
| Capital Expenditures | -69.1 | -218 | -125 | -409 | -777 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -278 | -259 | 12,951 | 4,713 | 880 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -348 | -477 | 12,826 | 4,303 | 102 |
| Financing Cash Flow Items | -451 | -994 | -3,898 | -36 | -25.7 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 907 | -471 | -11,759 | -184 | -28.1 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 258 | 119 | -17.3 | -105 | 73.2 |